DICLOFENAC 50 OETHMAAN


Enteric-coated tablet 9
scheduling status
S2
registration number
V/3.1/137
What DICLOFENAC 50 OETHMAAN is and what it is used for
DICLOFENAC 50 OETHMAAN belongs to a group of medicines called “non-steroidal anti-inflammatory drugs” (NSAIDs), which are used to treat pain and inflammation. DICLOFENAC 50 OETHMAAN is indicated for the treatment of:  Painful musculoskeletal conditions.  Rheumatism.  Acute attacks of gout.  Inflammation, pain and swelling after operations.  Pain following dental surgery.  Flare-up of osteoarthrosis (disease that causes painful joints).  Symptomatic treatment of menstrual pain.  Classical migraine headaches.
dosage
Adults: Initial daily dose: 100 to 150 mg in two to three divided doses, with a maximum daily dose of 150 mg in divided doses. Milder cases: 75 to 100 mg daily in divided doses. Menstrual pain: 50 to 150 mg daily in divided doses. Dosage should be individually determined. Treatment should be initiated at onset of symptoms and continued for a few days, depending on the intensity of pain. Classical migraine: 50 mg taken at first signs of an impending attack. If pain relief is not sufficient within 2 hours after the first dose, a second dose of 50 mg may be taken. A third dose may be taken after 4 to 6 hours if necessary but the total daily dose of 150 mg must not be exceeded.
how to take
Always take DICLOFENAC 50 OETHMAAN exactly as your doctor has instructed you. You should check with your doctor if you are unsure. If you have the impression that the effect of DICLOFENAC 50 OETHMAAN is too strong or too weak, talk to your doctor or pharmacist. These tablets should not be crushed, chewed or broken.
What DICLOFENAC 50 OETHMAAN contains
Diclofenac sodium.
other ingredients
Colloidal silicon dioxide, microcrystalline cellulose, lactose, maize starch, sodium starch glycolate, povidone K30, magnesium stearate, coating containing hydroxypropylmethyl cellulose, talc, polyethylene glycol, iron oxide red (CI number 77492), iron oxide yellow (CI number 77492), titanium dioxide (CI number 77891), methacrylic acid and ethyl acrylate copolymer, colloidal anhydrous silica, sodium bicarbonate, sodium lauryl sulfate.
Therapeutic classification
A.3.1 Antirheumatics (anti-inflammatory agents).
© 2026 SAHPRA. ALL RIGHTS RESERVED